Press Contact: Emily Passer * Based on a retrospective study of self-reported data of pounds lost for active versus passive users who were offered the Noom program when being prescribed an early stage GLP-1.
Read more on Peptide Nootropics and potential supplement alternatives
Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors, represents the next generation, and the retatrutide calculator supports dosing for those exploring that compound
The FDA's 2024 safety review noted cases of suicidal thoughts reported in post-marketing surveillance, but the incidence rate and causal link remain unclear
Monster packs a powerful punch but has a smooth easy drinking flavor
A more concentrated solution (e.g., 10mg/mL) is useful for larger doses with small injection volumes